,i #aaith ,,congress #b;d ,session ,h4 ,r4 #ghfg ,,in ,,the ,,house ,,of ,,representatives ,march #i1 #bjbf ,ms4 ,de,lauro 7for herself1 ,mrs4 ,grijalva1 ,mr4 ,panetta1 ,ms4 ,jacobs1 ,ms4 ,norton1 ,ms4 ,wilson of ,florida1 ,mr4 ,bishop1 ,ms4 ,williams of ,georgia1 ,mr4 ,pappas1 ,mr4 ,quigley1 ,mr4 ,krishnamoorthi1 ,ms4 ,schakowsky1 ,ms4 ,tlaib1 ,mr4 ,thanedar1 ,ms4 ,ross1 ,mr4 ,van ,drew1 ,ms4 ,dean of ,pennsylvania1 and ,mr4 ,cohen7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities1 to mandate notification of specific positive tests and inspection classifications1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,infant ,formula ,safety ,modernization ,act of #bjbf4 #b4 ,measures to enhance the safety of infant formula 7a7 ,good manufacturing practices 7#a7 ,in general ,section #dab7;b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7b77 is amended by adding at the end the following3 7#e7 7,a7 ,the ,secretary shall by regulation update the good manufacturing practices for infant formulas established under this subsection to require the manufacturer of an infant formula to conduct pathogen and microorganism testing of-- 7i7 the infant formula manufacturing facilities of the manufacturer2 and 7ii7 in addition to other applicable testing requirements under this ,act1 the finished infant formula product of the manufacturer4 7,b7 ,the regulations issued under subparagraph 7,a7 shall-- 7i7 require the ,commissioner of ,food and ,drugs to develop a list of pathogens and microorganisms that infant formula manufacturers must test for in infant formula manufacturing facilities and finished infant formula products1 which list shall include clostridium botulinum and such other pathogens and microorganisms as the ,secretary designates2 7ii7 specify the recommended frequency of environmental testing1 including requirements for testing in ,zones #b and #c of an infant formula manufacturing facility2 7iii7 require the manufacturer of an infant formula to submit to the ,secretary a written notification of any positive test result for a pathogen or microorganism referred to in clause 7i7 in infant formula1 not later than one business day following the date of the result1 even if the formula has not left the control of the manufacturer2 7iv7 for the purposes of inspections conducted under this ,act1 require the manufacturer of an infant formula to retain records of any positive test result for a pathogen or microorganism referred to in clause 7i7-- 7,i7 in infant formula2 or 7,,ii7 in the infant formula manufacturing facility of the manufacturer2 and 7v7 require ,commissioner of ,food and ,drugs to establish and enforce clear1 consistent inspection and compliance standards for all infant formula products1 regardless of their country of origin4 7,c7 ,in this paragraph3 7i7 ,the term ,zone #b1 with respect to an infant formula manufacturing facility1 means areas directly adjacent to locations where infant formula could be exposed during manufacturing1 but that are not food-contact surfaces4 7ii7 ,the term ,zone #c1 with respect to an infant formula manufacturing facility1 means areas further away from direct infant formula exposure than ,zone #b1 yet still within the processing environment2 contamination in ,zone #c could reach ,zone #b 7and thus the infant formula7 through movement of people1 equipment1 or airflow4 4 7#b7 ,deadline ,not later than #ij days after the date of enactment of this ,act1 the ,secretary shall issue final regulations under section #dab7;b77#e77;,a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7as added by paragraph 7#a7 of this subsection74 7b7 ,congressional notification requirements ,section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7 is amended by adding at the end the following3 7n7 ,congressional notification requirements 7#a7 ,if the ,secretary receives from a manufacturer a written notification of any test result that is a positive analytical result for a pathogen or microorganism in finished infant formula pursuant to subsection 7b77#e77;,b77iii71 the ,secretary shall1 not later than one business day following the date of such receipt1 provide a written notice of such receipt to the appropriate committees of ,congress4 7#b7 ,if the ,food and ,drug ,administration issues an official action indicated classification 7or an equivalent classification7 following an inspection of an infant formula manufacturing facility1 the ,secretary shall1 not later than one business day following the date of such issuance1 provide a written notice of such issuance to the appropriate committees of ,congress4 7#c7 ,in this subsection1 the term appropriate committees of ,congress means-- 7,a7 the ,committee on ,appropriations and the ,committee on ,energy and ,commerce of the ,house of ,representatives2 and 7,b7 the ,committee on ,appropriations and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate4 4 7c7 ,conforming amendment ,section #dab7;b77#d77;,a77i7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7b77#d77;,a77i77 is amended by striking paragraph 7#b77;,b7 and inserting paragraphs 7#b77;,b7 and 7#e77;,a74